1. Home
  2. RCON vs PDSB Comparison

RCON vs PDSB Comparison

Compare RCON & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCON
  • PDSB
  • Stock Information
  • Founded
  • RCON 2007
  • PDSB 2005
  • Country
  • RCON China
  • PDSB United States
  • Employees
  • RCON N/A
  • PDSB N/A
  • Industry
  • RCON Oilfield Services/Equipment
  • PDSB Biotechnology: Pharmaceutical Preparations
  • Sector
  • RCON Energy
  • PDSB Health Care
  • Exchange
  • RCON Nasdaq
  • PDSB Nasdaq
  • Market Cap
  • RCON 45.3M
  • PDSB 43.1M
  • IPO Year
  • RCON 2009
  • PDSB N/A
  • Fundamental
  • Price
  • RCON $1.66
  • PDSB $1.32
  • Analyst Decision
  • RCON
  • PDSB Strong Buy
  • Analyst Count
  • RCON 0
  • PDSB 3
  • Target Price
  • RCON N/A
  • PDSB $10.00
  • AVG Volume (30 Days)
  • RCON 13.3K
  • PDSB 279.1K
  • Earning Date
  • RCON 06-28-2024
  • PDSB 05-14-2025
  • Dividend Yield
  • RCON N/A
  • PDSB N/A
  • EPS Growth
  • RCON N/A
  • PDSB N/A
  • EPS
  • RCON N/A
  • PDSB N/A
  • Revenue
  • RCON $8,996,572.00
  • PDSB N/A
  • Revenue This Year
  • RCON N/A
  • PDSB N/A
  • Revenue Next Year
  • RCON $12.17
  • PDSB N/A
  • P/E Ratio
  • RCON N/A
  • PDSB N/A
  • Revenue Growth
  • RCON N/A
  • PDSB N/A
  • 52 Week Low
  • RCON $1.32
  • PDSB $0.85
  • 52 Week High
  • RCON $3.70
  • PDSB $4.42
  • Technical
  • Relative Strength Index (RSI)
  • RCON 49.18
  • PDSB 60.87
  • Support Level
  • RCON $1.45
  • PDSB $1.00
  • Resistance Level
  • RCON $1.97
  • PDSB $1.17
  • Average True Range (ATR)
  • RCON 0.14
  • PDSB 0.11
  • MACD
  • RCON -0.01
  • PDSB 0.04
  • Stochastic Oscillator
  • RCON 44.23
  • PDSB 98.95

About RCON Recon Technology Ltd.

Recon Technology Ltd is an oilfield service company. The company is engaged in providing oilfield automation products, specialized equipment for oil and gas production and transportation, chemicals, and field services to petroleum companies mainly in the People's Republic of China (PRC). It has four reportable operating segments: Automation Product and Software, Equipment and Accessories, Platform outsourcing services, and Oilfield Environmental Protection. The majority of the firm's revenue comes from the Automation Product and Software segment which provides products and services like pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system among others.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: